当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0420
Central Admixture Pharmacy Services, Inc.
2024-2
GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
72196-0420-1
Trophamine 4.5%/Dextrose 10% With Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
71285-0432
Central Admixture Pharmacy Services, Inc.
2024-2
SERINE; GLUTAMIC ACID; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM; LYSINE ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.4275 g/250 mL; .5625 g/250 mL; .0495 g/250 mL; .27 g/250 mL; .4725 g/250 mL; .027 g/250 mL; .54 g/250 mL; 1.35 g/250 mL; .028125 g/250 mL; 25 g/250 mL; 1.575 g/250 mL; .3825 g/250 mL; .765 g/250 mL; .36 g/250 mL; .09225 g/250 mL; .6075 g/250 mL; .405 g/250 mL; .54 g/250 mL; .225 g/250 mL; .8775 g/250 mL; 125 U/250 mL; 1.35 g/250 mL
71285-0432-1
Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag
HUMAN COMPOUNDED DRUG
71285-0431
Central Admixture Pharmacy Services, Inc.
2024-2
CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL
71285-0431-1
Methionine Inositol Choline
HUMAN COMPOUNDED DRUG
26436-2632
Hybrid Pharma
2024-2
METHIONINE; INOSITOL; CHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL
26436-2632-3
Calcium Gluconate
HUMAN COMPOUNDED DRUG
26436-5005
Hybrid Pharma
2024-2
CALCIUM GLUCONATE MONOHYDRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL
26436-5005-2
Methylcobalamin
HUMAN COMPOUNDED DRUG
26436-5015
Hybrid Pharma
2024-2
METHYLCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
26436-5015-3
Glutathione
HUMAN COMPOUNDED DRUG
26436-5028
Hybrid Pharma
2024-2
GLUTATHIONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL
26436-5028-3
Magnesium Chloride
HUMAN COMPOUNDED DRUG
26436-5105
Hybrid Pharma
2024-2
MAGNESIUM CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
26436-5105-5
Estriol
HUMAN COMPOUNDED DRUG
26436-5343
Hybrid Pharma
2024-2
ESTRIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg
26436-5343-1
ASCORBIC ACID
HUMAN COMPOUNDED DRUG
26436-5001
Hybrid Pharma
2024-2
ASCORBIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
500 mg/1 mL
26436-5001-5
Panthenol 250mg/mL
HUMAN COMPOUNDED DRUG
26436-5007
Hybrid Pharma
2024-2
PANTHENOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
250 mg/1 mL
26436-5007-3
Methylprednisolone Acetate
HUMAN COMPOUNDED DRUG
72907-2115
Brookfield Medical Surgical Supply
2024-2
METHYLPREDNISOLONE ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/40 mL
72907-2115-3
Methylprednisolone Acetate
HUMAN COMPOUNDED DRUG
72907-2115
Brookfield Medical Surgical Supply
2024-2
METHYLPREDNISOLONE ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/40 mL
72907-2115-5
Betamethasone Sodium Phosphate
HUMAN COMPOUNDED DRUG
72907-1821
Brookfield Medical Surgical Supply
2024-2
BETAMETHASONE SODIUM PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg/6 mL
72907-1821-3
Morphine Sulfate
HUMAN COMPOUNDED DRUG
72907-2467
Brookfield Medical Surgical Supply
2024-2
MORPHINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/25 mL
72907-2467-1
Potassium Phosphate 15mmol added to NS
HUMAN COMPOUNDED DRUG
71285-6060
Central Admixture Pharmacy Services, Inc.
2024-1
POTASSIUM PHOSPHATE, DIBASIC
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 mmol/250 mL
71285-6060-1
Bevacizumab
HUMAN COMPOUNDED DRUG
71449-091
Denver Solutions, LLC dba Leiters Health
2024-1
BEVACIZUMAB
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL
71449-091-90
Ketamine
HUMAN COMPOUNDED DRUG
71449-068
Denver Solutions, LLC dba Leiters Health
2024-1
KETAMINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71449-068-32
Ketamine
HUMAN COMPOUNDED DRUG
71449-068
Denver Solutions, LLC dba Leiters Health
2024-1
KETAMINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71449-068-11
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
71449-013
Denver Solutions, LLC dba Leiters Health
2024-1
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
71449-013-32
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3